US Supreme Court Will Hear Case Regarding Regulation of Abortion Pill
In August, the US Court of Appeals for the Fifth Circuit ruled that mifepristone can remain on the market in Alliance for Hippocratic Medicine v. US Food and Drug Administration +mdash; but only under the conditions for use from 2016…. by Cassy Fiano-Chesser
Leave a Reply